论文部分内容阅读
宫内节育器是国内外适龄女性普遍采用的一种避孕方法,该方法具有安全、方便、长效的特点。但是节育器作为一种体外异物放置到子宫腔内,会引起女性子宫内膜及周围组织产生众多不适反馈。宫内节育器放置后子宫异常出血是其中最为常见反应。妈富隆属于第三代合成性孕激素,属于临床新型避孕药物。更加容易作用与机体组织。与传统药物相比,妈富隆不会增加患者血液中游离睾酮水平。相关研究也证明妈富隆内几乎无雄激素活性,因此口服用药后不会对患者脂代谢功能产生影响,兼具药疗效果好和用药安全可靠的临床优势。可用于改善大多数妇女放置宫内节育器后子宫异常出血的现象,值得进行临床推广。
IUD is a contraceptive method commonly used by women of the same age both at home and abroad. The method is safe, convenient and long-lasting. But IUD as an extracorporeal foreign body placed in the uterine cavity, will cause a lot of female endometrial and surrounding tissue produce a lot of discomfort feedback. Intrauterine device placed abnormal uterine bleeding is one of the most common reaction. Marvelon is the third generation of synthetic progestin, a new clinical contraceptives. Easier to function with body tissue. Marvelon does not increase the level of free testosterone in the blood of patients compared to traditional medicines. Related research also proves that Marvelon almost no androgen activity, so oral medication will not affect the patient’s lipid metabolism, both with good drug efficacy and drug safety and reliability of clinical advantages. Can be used to improve the majority of women after the placement of IUD abnormal uterine bleeding phenomenon, worthy of clinical promotion.